Flagship Pioneering Fund VII, L.P.

Track

Insider profile

Flagship Pioneering Fund VII, L.P.'s trades of Syros Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
85.35
Quantity 79,897
Value US$64,809
Transaction date
Proposed sale
Price
392.60
Quantity 55,648
Value US$1,819,944
Transaction date
Proposed sale
Price
375.03
Quantity 77,787
Value US$348,329
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-16 2024-12-27
PrS Proposed sale
79,897
85.35
US$64,809 		79,897 85.35 US$64,809
2024-12-27 2024-12-27
PrS Proposed sale
55,648
392.60
US$1,819,944 		55,648 392.60 US$1,819,944
2024-12-13 2024-12-13
PrS Proposed sale
77,787
375.03
US$348,329 		77,787 375.03 US$348,329